France vs South Sudan: The number of people with susceptibility test result for rifampicin
France
1.45
in 2021
South Sudan
0
in 2021
France rank
141st
South Sudan rank
142nd
The number of people with susceptibility test result for rifampicin over time
- France
- South Sudan
How they compare
France currently reports 1.45 against 0 in South Sudan, a difference of 1.45.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was France ahead.
France ranks 141st and South Sudan ranks 142nd of 146 countries.
Across the 2 decades both report, France averaged higher in 1 and South Sudan in 1.
Head to head by decade
| Decade | France | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 137.55 | 1.82 | 135.74 | France |
| 2020s | 1.66 | 2.31 | 0.6413 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, France or South Sudan?
- France, at 1.45 against 0 in South Sudan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between France and South Sudan?
- 1.45, with France ahead.
- How many years of comparable data are there for France and South Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do France and South Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- France ranks 141st and South Sudan ranks 142nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.